James M. Hewitt

Array ( [id] => 16695443 [patent_doc_number] => 10946012 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => Methods for inducing tumor regression, inhibiting tumor growth, and inducing apoptosis in breast tumors with geranylgeranyltransferase I inhibitors [patent_app_type] => utility [patent_app_number] => 13/194022 [patent_app_country] => US [patent_app_date] => 2011-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 7432 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13194022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14420049 [patent_doc_number] => 10314810 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-11 [patent_title] => Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics [patent_app_type] => utility [patent_app_number] => 13/812375 [patent_app_country] => US [patent_app_date] => 2011-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 28200 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757921 [patent_doc_number] => 20120029418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'COMPOSITION AND METHOD FOR PHOTODYNAMIC DISINFECTION' [patent_app_type] => utility [patent_app_number] => 13/190857 [patent_app_country] => US [patent_app_date] => 2011-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9662 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029418.pdf [firstpage_image] =>[orig_patent_app_number] => 13190857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784743 [patent_doc_number] => 20120046299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'METHOD OF TREATING ARRHYTHMIAS' [patent_app_type] => utility [patent_app_number] => 13/190300 [patent_app_country] => US [patent_app_date] => 2011-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 63 [patent_no_of_words] => 24829 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046299.pdf [firstpage_image] =>[orig_patent_app_number] => 13190300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8904905 [patent_doc_number] => 20130172408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'Medicaments Based on Dinuclear Arene Ruthenium Complexes Comprising Bridging Thiolato, Selenolato or Alkoxo Ligands' [patent_app_type] => utility [patent_app_number] => 13/810932 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17359 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720839 [patent_doc_number] => 20120010174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'CALCIUM/SODIUM SALT OF INOSITOL TRIPYROPHOSPHATE AS AN ALLOSTERIC EFFECTOR OF HEMOGLOBIN' [patent_app_type] => utility [patent_app_number] => 13/176499 [patent_app_country] => US [patent_app_date] => 2011-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11295 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010174.pdf [firstpage_image] =>[orig_patent_app_number] => 13176499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663767 [patent_doc_number] => 20110313036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG' [patent_app_type] => utility [patent_app_number] => 13/164620 [patent_app_country] => US [patent_app_date] => 2011-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9667 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313036.pdf [firstpage_image] =>[orig_patent_app_number] => 13164620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7711849 [patent_doc_number] => 20120004188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'USE OF RANOLAZINE FOR TREATING PULMONARY HYPERTENSION' [patent_app_type] => utility [patent_app_number] => 13/160393 [patent_app_country] => US [patent_app_date] => 2011-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8804 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13160393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11519974 [patent_doc_number] => 09603354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Protective solutions for organs' [patent_app_type] => utility [patent_app_number] => 13/152056 [patent_app_country] => US [patent_app_date] => 2011-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5395 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13152056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11762944 [patent_doc_number] => 09371301 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-21 [patent_title] => 'Prenylarene compound and use thereof' [patent_app_type] => utility [patent_app_number] => 13/696425 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 11342 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167524 [patent_doc_number] => 20110195962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'USE OF MULTI-PHARMACOPHORE COMPOUNDS TO TREAT NASAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/088719 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2975 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195962.pdf [firstpage_image] =>[orig_patent_app_number] => 13088719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110427 [patent_doc_number] => 20110189281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'TELMISARTAN AND HYDROCHLOROTHIAZIDE COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 13/087887 [patent_app_country] => US [patent_app_date] => 2011-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5304 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189281.pdf [firstpage_image] =>[orig_patent_app_number] => 13087887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8977436 [patent_doc_number] => 20130210867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'METHODS AND COMPOSITIONS FOR ENHANCING FEMALE SEXUAL AROUSAL AND TREATING FEMALE SEXUAL DYSFUNCTION' [patent_app_type] => utility [patent_app_number] => 13/640518 [patent_app_country] => US [patent_app_date] => 2011-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4350 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113310 [patent_doc_number] => 20110190277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'PHARMACEUTICAL COMBINATION FOR THE PREVENTION OR TREATMENT OF CARDIOVASCULAR, CARDIOPULMONARY, PULMONARY OR RENAL DISEASES' [patent_app_type] => utility [patent_app_number] => 13/086131 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10572 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190277.pdf [firstpage_image] =>[orig_patent_app_number] => 13086131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113540 [patent_doc_number] => 20110190312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Combinations Comprising Epothilones and Protein Tyrosine Kinase Inhibitors and Pharmaceutical Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/085519 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5150 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190312.pdf [firstpage_image] =>[orig_patent_app_number] => 13085519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063421 [patent_doc_number] => 20110245314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Extended Release Formulation and Methods of Treating Adrenergic Dysregulation' [patent_app_type] => utility [patent_app_number] => 13/082724 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11377 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245314.pdf [firstpage_image] =>[orig_patent_app_number] => 13082724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8940504 [patent_doc_number] => 20130190301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'PIROXICAM FOR PROPHYLACTICALLY AND THERAPEUTICALLY TREATING HERPES INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/639357 [patent_app_country] => US [patent_app_date] => 2011-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1091 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13639357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7568052 [patent_doc_number] => 20110288115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'TREATMENT OF VAGALLY-MEDIATED SPECTRUM DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/040122 [patent_app_country] => US [patent_app_date] => 2011-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3435 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288115.pdf [firstpage_image] =>[orig_patent_app_number] => 13040122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5973104 [patent_doc_number] => 20110152329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Use of Epothilone Derivatives for the Treatment of Hyperparathyroidism' [patent_app_type] => utility [patent_app_number] => 13/037989 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2443 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152329.pdf [firstpage_image] =>[orig_patent_app_number] => 13037989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969343 [patent_doc_number] => 20110151023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'COMBINATION THERAPY WITH PARP INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/037691 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9406 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20110151023.pdf [firstpage_image] =>[orig_patent_app_number] => 13037691 [rel_patent_id] =>[rel_patent_doc_number] =>)